Treating Tobacco Use and Dependence CME/CE

Author Information and Disclosures

Release Date: November 17, 2004; Reviewed and Renewed: February 29, 2008; Valid for credit through March 1, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 ANCC contact hours

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Note: New Warning on Varenicline

Use with caution in patients with significant kidney disease (creatinine clearance < 30mL/min) or who are on dialysis. Dose should be reduced with these patients. Depressed mood, agitation, changes in behavior, suicidal ideation, and suicide have been reported in patients attempting to quit smoking while using varenicline. This information is now included in the FDA package insert as a warning.

Watch for an update on this activity to be published mid 2008.
  1. Treating Tobacco Use and Dependence: Module 1Michael C. Fiore, MD, MPH
  2. Treating Tobacco Use and Dependence: Module 2Michael C. Fiore, MD, MPH
  3. Treating Tobacco Use and Dependence: Module 3Michael C. Fiore, MD, MPH
  4. Treating Tobacco Use and Dependence: Module 4Michael C. Fiore, MD, MPH
  5. Treating Tobacco Use and Dependence: Special PopulationsMichael C. Fiore, MD, MPH


Research Opportunity
Faculty and students at the University of Wisconsin School of Medicine and Public Health are conducting a follow-up study of the CME activity you have just completed, titled "Treating Tobacco Use and Dependence".

A telephone interview will be the method of obtaining information about the ways physicians address tobacco use and dependence with their patients. Physician participants may benefit by learning of evidence-based treatment methods and by comparing their smoking cessation results with aggregate data collected during the study.

To leave Medscape and learn more about this research opportunity, click here. After leaving this site, Medscape's privacy policies will no longer apply to your participation.

Legal Disclaimer

The materials presented here do not necessarily reflect the views of Medscape, The University of Wisconsin School of Medicine and Public Health, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

This CME activity "Treating Tobacco Use and Dependence" was originally offered as an online Web-based program certified for CME.

Copyright © 2004 the University Board of Regents.
Medscape, UW-CTRI
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the rationale for treating tobacco dependence
  2. Explain why tobacco dependence is a chronic disease
  3. Initiate clinical interventions for tobacco users willing to quit as well as users not willing to make a quit attempt
  4. Assist users attempting to quit with strategies designed to prevent relapse
  5. Implement appropriate strategies to assist special populations of smokers
Authors and Disclosures

Michael C. Fiore, MD, MPH
Disclosure: In keeping with recent JAMA recommendations, Dr. Fiore does not accept honoraria nor does he consult for the pharmaceutical industry. In 1998, The University of Wisconsin (UW) appointed Dr. Fiore to a named Chair, made possible by an unrestricted gift to UW from Glaxo Wellcome.
 
The University of Wisconsin School of Medicine and Public Health
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

The University of Wisconsin School of Medicine and Public Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This continuing nursing education activity was approved by the Wisconsin Nurses Association Continuing Education Approval Program Committee, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Approved for 1.0 contact hour(s) of continuing education for RNs, LPNs, LVNs and NPs.
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.